Braunstein, L. Z., Mitchell, M., Bandos, H., Sikov, W. M., Khan, A. J., Chen, P. Y., Ganz, P. A., Jagsi, R., White, J. R., Cecchini, R. S., Kang, H., Puhalla, S. L., Bolton, K. L., Connolly, E., Stringer-Reasor, E. M., Gergelis, K., Julian, T. B., Mamounas, E. P., Wolmark, N. (2025). A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps1120